摘要
目的:探讨中华眼镜蛇毒卡迪(KD)中进一步分离纯化的10个组分KDⅠ-1、KDⅠ-1H、KDⅠ-2、KDQⅠ-2、KDⅡ、KDⅡ-2、KDⅡ-3,KDⅢ-1,KDⅢ-2和KDⅢ-2对神经胶质瘤细胞U251的抑制作用。方法:采用MTT法和台盼蓝拒染法观察各组分对U251细胞增殖的影响。结果:在1~100μg/ml.的浓度范围内用MTT法筛选出3个具有显著抑制作用的组分KD、KDⅡ-3和KDⅢ-1,对以上3种组分再次细分浓度后(5、10、30、50、80、100μg/mL)的MTT结果显示以上三种组分仍然具有显著的抑制作用。选取了KDⅢ-1和KDⅡ-3进一步细分浓度后(1、3.75、7.5、15、30μg/ml,)的MTT结果显示KDⅢ-1和KDⅡ-3组分在7.5μg/mL时的抑制率分别为63.94%和62.15%,且2种组分在1~30μg/mL。呈现剂量效应关系(r=0.694,P〈0.05;r=0.732,P〈0.05)。半数抑制浓度分别为6.65μg/mL;和10。54μg/mL,KDⅡ-3的生长曲线显示药物的各个浓度(1、3.75、7.5、15、30μg/mL)对肿瘤细胞均有抑制作用,以24h的抑制作用最为明显。在7.5-15μg/mL浓度范围内呈现明显抑制作用。结论:分离纯化的10组分对U251细胞有不同程度的抑制作用,无以KDⅡ-3的抑制作用最为显著,并有明显的剂量效应关系。
Objective:To observe the growth inhibitory effects of 10 peplides (KD Ⅰ-1, KD Ⅰ-1 H, KD Ⅰ-2, KD Q Ⅰ-2, KD Ⅱ, KD Ⅱ-2, KD Ⅱ-3, KDⅢ-1 , KD Ⅲ-2, KD Ⅲ-2') purified from KD, one of components in Naja Naja Actra venom, on human glioma U251 cell line. Methods: The growth inhibition by each peptide in U251 was studied with MTT assay and trypan blue exclusion. Results: MTT assay screened out three eomponents (KD, KD Ⅱ-3 and KD Ⅲ-1 ) with significant growth inhibition on U251 within 1-100μg/mL interval of levels. MTr assay of these components at further classified levels (5, 10, 30, 50, 80 and 100μg/mL) reconfirmed such inhibitory effects. When KD Ⅱ-3 and KD Ⅲ-1 were selected to be tested at more specified sublevels ( 1, 3.75, 7.5, 15 and 30μg/mL) , maximum rates of inhibition were observed for KD Ⅲ-1 (63.94%) and KD Ⅱ-3 (62.15%) at a level of 7.5ug/mL. Furthermore, the both showed dose-effect correlations (r = 0. 694, P 〈 0. 05 ; r = 0. 732, P 〈 0.05, respectively) with 1-30ug/mL interval of levels. The IC50 was 6.65ug/mL and 10.54ug/mL, respectively. The KDⅡ-3 inhibited growth curve suggested evidenced inhibition on U251 at all specified sublevels, which appeared to be more remarkable with the 7.5-15μg/mL interval, and was most significant at 24 hours. Conclusion: 10 KD-purified peptides were shown to have varied inhibitory effect on the growth of U251. Among them, KDⅡ-3 resulted in the most remarkable inhibition with an identifiahle dose-effect correlation.
出处
《广州医学院学报》
2006年第4期25-28,共4页
Academic Journal of Guangzhou Medical College
基金
广东省自然科学基金(2004102537)